SaifM. “U.S. Food and Drug Administration Approves Paclitaxel Protein-Bound Particles (Abraxane®) in Combination With Gemcitabine As First-Line Treatment of Patients With Metastatic Pancreatic Cancer”. JOP. Journal of the Pancreas, Vol. 14, no. 6, Nov. 2013, pp. 686-8, doi:10.6092/1590-8577/2028.